USPTO serial 79356433
KANGENDE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 4, 2025
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with KANGENDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Shenyang Kangende Medical Science and Technology Co., Ltd.
CN
Other trademarks owned by Shenyang Kangende Medical Science and Technology Co., Ltd.
Shenyang Kangende Medical Science and Technology Co., Ltd.
CN
Other trademarks owned by Shenyang Kangende Medical Science and Technology Co., Ltd.
Shenyang Kangende Medical Science and Technology Co., Ltd.
CN
Other trademarks owned by Shenyang Kangende Medical Science and Technology Co., Ltd.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic publications, downloadable in the nature of books in the field of keratoscope and ophthalmic instruments related to keratoscope; downloadable image files containing keratoscope and ophthalmic products; computer programs, downloadable for accessing and viewing information about ophthalmic instruments; downloadable cellular phone applications for accessing and viewing information about ophthalmic instruments; recorded digital video disc featuring videos on ophthalmic instruments; electronic chips for the manufacture of integrated circuits | ACTIVE | — |
| 010 | Medical devices and instruments for medical examination or diagnostic uses relating to vision, ocular anterior segment, intraocular, and intraocular pressure examination, namely, visual acuity charts, optometric autorefractors, slit-lamp microscopes, corneal topographers, ophthalmoscopes, retinal cameras, OCT optical coherence tomography scanners, tonometers, microscopes, and flow cytometers; Medical apparatus and instruments relating to ophthalmic examination and surgery for the purpose of vision correction or ophthalmic implant, namely, rigid, soft and orthokeratology lenses, intraocular lenses, and implantable collamer lenses; Medical apparatus and instruments relating to ophthalmic examination and surgery for the purpose of ophthalmic physiotherapy, namely, lasers for ophthalmic purposes, phacoemulsification ultrasound devices for the treatment of cataracts, eye heating and cooling devices in the nature of eye masks, MRI magnetic resonance imaging equipment, and vision training devices for training eye muscles and for eye-tracking and neural adaptation; Sterilized ocular medical examination instruments relating to inspection and measurement, namely, corneal endothelial microscopes, ocular A/B ultrasound devices, and wavefront aberrometers; Sterilized surgical instruments relating to ophthalmic surgery, microsurgery, suturing, and intraocular injections, namely, cataract surgery knives, corneal knives, surgical vitrectomy lenses, micro forceps, micro scissors, needle holders, and surgical sutures; Sterilizating and disinfecting medical instruments relating to ophthalmic examination and surgery, namely, sterile surgical gloves, disposable syringes and needles and bandage lense; Ophthalmic diagnostic equipment for medical purposes for vision, anterior segment, intraocular, and intraocular pressure examination, namely, visual acuity charts, automatic refractors, slit-lamp microscopes, corneal topographers, ophthalmoscopes, retinal cameras, OCT optical coherence tomography scanners, tonometers, and slit lamps; surgical mirrors for surgeons; Physiotherapy equipment for ophthalmic examination and surgery, namely, laser treatment devices for ophthalmic purposes, phacoemulsification ultrasound devices for the treatment of cataracts, eye heating and cooling devices in the nature of eye masks, MRI magnetic resonance imaging equipment, vision training devices for training eye muscles and for eye-tracking and neural adaptation; medical devices for facilitating the inhalation of pharmaceutical preparations, namely, anaesthetic inhalers sold empty | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shenyang Kangende Medical Science and Technology Co., Ltd.
- Other trademarks owned by Shenyang Kangende Medical Science and Technology Co., Ltd.
- Other trademarks owned by Shenyang Kangende Medical Science and Technology Co., Ltd.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named KANGENDE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 14, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 14, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 4, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 4, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 14, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 14, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 8, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 9, 2024 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Nov 9, 2024 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Nov 9, 2024 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Aug 27, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 27, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 1, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 1, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 12, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 12, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 12, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 17, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 17, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 16, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 15, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 25, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 6, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |